Shortcuts 2021 2020 2018 2017


  • Empowered Patient Podcast
    Optimizing Autologous Cell Therapy to Treat Cardiovascular Disease with Dr. Peter Altman Read More

  • UW Health
    UW Health Treats First Patient in U.S. with Investigational Cell Therapy for Heart Disease Read More

  • Greenbay CBS
    Neenah musician, educator pursues dream after being first in the world to undergo ‘Investigational Cell Therapy’ Read More

    Neenah man gets new lease on life after trial heart procedure Read More

  • Henry Ford Health System
    Henry Ford Health System Studies Novel Cell Therapy Aimed at Improving Heart Failure Symptoms Read More

  • Cell & Gene
    Inside BioCardia's CardiAMP Cell Therapy Read More


  • BioTuesdays
    BioCardia developing autologous and allogenic cardiovascular cell therapies Read More

  • Pharmaceutical Technology
    BioCardia’s novel CardiAMP stem cell therapy closer to approval in heart failure Read More

  • The Big Biz show
    The Big Biz Show interviews BioCardia CEO, Peter Altman Read More

  • HealthCare Weekly
    5 Innovations That Will Change the Treatment of Heart Disease Read More


  • Cardiology Today
    Ongoing trial assessing novel assay to determine response to cardiac regenerative therapy Read More

  • BioWorld Med Tech
    Biocardia wins IDE for cell therapy as treatment for angina Read More


  • BioWorld Med Tech
    Biocardia presses on with Cardiamp pivotal trial to treat patients with heart failure Read More

  • Med Latest
    BioCardia® Helix Results in Higher Stem Cell Retention in Myocardium Read More

  • Fox 47
    UW Health trial involves injecting stem cells into patients with heart failure Read More

  • Medical press
    First participant treated in trial of stem-cell therapy for heart failure Read More

  • Cardiology today
    First patient treated in trial of novel cell therapy Read More

  • News Center Watch
    Johns Hopkins, MSCRF, BioCardia treat first patient with CardiAMP in ischemic heart failure trial Read More

  • Drug Delivery
    BioCardia, Johns Hopkins treats first patient with CardiAmp cell therapy in Phase III trial Read More

  • The Baltimore Sun
    Patient's own bone marrow used to treat heart failure Read More


Have questions?
: (800) 624-1179
Have questions?

biocardia takes a new and comprehensive
approach to heart failure

By introducing patient screening and highly-efficient delivery to stem cell therapy, the company seeks to increase the likelihood of treatment success, enabling more patients to return to the things they love.